Cancer
A unifying feature of cancer is that cancer cells have undergone genetic changes that disrupt normal regulation of cell proliferation and death. To improve strategies for preventing and treating cancer,we work to understand how genetic changes arise and how to block the pathogenic effects of these mutations.
| Name | Department |
|---|---|
| William Catalona, MD | Urology |
| Anjen Chenn, MD, PhD | Pathology |
| Kathleen Green, PhD | Pathology |
| Mary Hendrix, PhD | Robert H. Lurie Comprehensive Cancer Center |
| Robert Holmgren, PhD | Molecular Biosciences |
| Curt Horvath, PhD | Molecular Biosciences |
| Sui Huang, PhD | Cell and Molecular Biology |
| Sarah Jackson, MS, CGC | Center for Genetic Medicine |
| William Karpus, PhD | Pathology |
| Warren Kibbe, PhD | Center for Genetic Medicine |
| Peter Kopp, MD | Center for Genetic Medicine |
| Takeshi Kurita, PhD | Obstetrics and Gynecology |
| Laimonis Laimins, PhD | Microbiology-Immunology |
| Chung Lee, PhD | Urology |
| Jonathan Leis, PhD | Microbiology-Immunology |
| Jonathan Licht, MD | Medicine |
| Richard Longnecker, PhD | Microbiology-Immunology |
| Yong-Chao Ma, PhD | Pediatrics, Neurology and Physiology |
| Kevin McVary, MD | Urology |
| Puneet Opal, MD, PhD | Neurology |
| Amy Paller, MD, MS | Pediatrics |
| Boris Pasche, MD, PhD | Medicine |
| Steven Rosen, MD, FACP | Medicine |
| Lee Shulman, MD, FACOG, FACMG | Obstetrics and Gynecology |
| Paula Stern, PhD | Molecular Pharmacology & Biological Chemistry |
| Kristen Vogel, MS, CGC | |
| Scott Weissman, MS/CGC | |
| Gayle Woloschak, PhD | Radiology |
| Jindan Yu, MD, PhD | Medicine |
| Ming Zhang, PhD | Molecular Pharmacology & Biological Chemistry |
| Yanming Zhang, MD | Pathology |
